Related Experiment Video
Updated: Apr 17, 2026

07:05
Orthotopic Injection of Breast Cancer Cells into the Mice Mammary Fat Pad
Published on: January 20, 2019
57.5K
Metaplastic breast carcinoma: more than a special type
Britta Weigelt1, Carey Eberle1, Catherine F Cowell1
1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Nature Reviews. Cancer
|February 18, 2015
Summary
Metaplastic breast carcinoma (MBC) is a rare invasive breast cancer subtype. This descriptive term covers diverse tumors with unique characteristics and treatment responses.
Area of Science:
- Oncology
- Pathology
Background:
- Metaplastic breast carcinoma (MBC) represents a rare histological subtype of invasive breast cancer.
- MBC is characterized by its heterogeneity, encompassing diverse tumor types.
Purpose of the Study:
- To define and describe the key features of metaplastic breast carcinoma.
- To highlight the heterogeneity within MBC regarding histology, clinical behavior, and therapeutic sensitivity.
Main Methods:
- Histopathological analysis of breast cancer tissues.
- Clinical data review of patient outcomes and treatment responses.
Main Results:
- MBC tumors exhibit distinct histologies compared to other breast cancers.
- Significant variations in clinical behavior and treatment responses are observed among MBC subtypes.
Conclusions:
- Metaplastic breast carcinoma is a complex and heterogeneous group of tumors.
- Understanding MBC's distinct characteristics is crucial for accurate diagnosis and tailored therapy.
Related Concept Videos
Metastasis
7.0K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
7.0K
Tumor Progression
8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K

